Halozyme Reaffirms It Projects Zero to Minimal Impact to Royalty Revenue Through At Least 2035 Based on Medicare Drug Price Negotiation Program Final Rule for IPAY 2029

The Quick Take
SAN DIEGO, Nov. 6, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme" or the "Company") today confirmed that the Company expects zero to minimal royalty revenue impact based on its analysis of the final rule for the Medicare Drug Price Negotiation Program...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Business
Introducing IAN: A New Longevity-Focused Wellness Company on a Mission to Put More Life Into Every Year
Debuting December 22, IAN brings foundational nutrition and longevity support together in one daily stack gummy WEST PALM BEACH, Fla., Nov. 6, 2026…
Business
Mazda da la bienvenida a la temporada con su evento anual de ventas de invierno e incentivos excepcionales para clientes
Concesionarios de todo el país ofrecen ahorros de hasta USD $3.000 en crossovers seleccionados hasta el 4 de enero de 2027 IRVINE, California, 6 de noviembre…
Business
In HelloNation, Moving Expert Mike Sheridan Outlines When to Hire Professional Packing Services Instead of Doing It Yourself
The Article Details How Time, Fragile Items, and Moving Timeline Help Households Decide Whether Packing Help Is the Right Choice. ROCHESTER, N.Y., Nov. 6, 2026…
Local
CALV Presents Nov. 13 “World of Commercial” Class for Local Real Estate Pros - Nevada Business Magazine
CALV Presents Nov. 13 “World of Commercial” Class for Local Real Estate Pros Nevada Business Magazine
